Analyst Ratings for aTyr Pharma (LIFE)

LIFE Rating Summary

LIFE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LIFE
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $8.00 (+175.9%) * Over Last 12-Mos
Rating Score: 2.5 / 10   Percentile Rank: 54%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/12/2016 BMO Capital New Coverage Market Perform
(N/A)
8.00
(N/A)
3.62 2.90 -19.89% Details
3/31/2016 William Blair Downgrade Market Perform
(Outperform)
N/A
(N/A)
4.86 2.90 -40.33% Details
Like LIFE Ratings? Also take a look at MDCO, ONE, OCX, NWPX

LIFE Ratings News